Safety of Promethazine for Motion Sickness
Promethazine is generally safe and effective for motion sickness in adults, but it carries significant side effect risks including sedation, dizziness, and anticholinergic effects that may limit its use in certain populations.
Efficacy and Indications
Promethazine is a phenothiazine derivative with antihistamine, sedative, anti-emetic, and anticholinergic properties that has been used for motion sickness for decades 1. The FDA-approved dosage for motion sickness is:
- 25 mg taken twice daily
- Initial dose should be taken 30-60 minutes before anticipated travel
- Repeated 8-12 hours later if necessary
- On subsequent travel days, 25 mg upon waking and again before the evening meal 1
Safety Profile and Side Effects
Promethazine carries several important safety considerations:
Common Side Effects
- Sedation/drowsiness (most prominent CNS effect) 1
- Dizziness and blurred vision 1
- Dry mouth 1
- Confusion and disorientation 1
Serious Adverse Effects
- Respiratory depression (potentially fatal) 1
- Extrapyramidal symptoms (oculogyric crisis, torticollis, tongue protrusion) 1
- Neuroleptic malignant syndrome (rare but potentially fatal) 1
- Cardiovascular effects (changes in blood pressure, tachycardia, bradycardia) 1
Contraindications and Precautions
Promethazine should be avoided in:
- Children under 2 years (black box warning) 1
- Patients taking MAO inhibitors 2
- Patients with psychosis 2
- Patients with glaucoma 2
- Patients with pre-existing liver disease 2
Special Populations
Elderly Patients
Older adults are at higher risk for side effects due to:
- Pre-existing comorbidities like prostatic hypertrophy
- Elevated intraocular pressure
- Cognitive impairment 2
These factors place elderly patients in a high-risk category for first-generation antihistamine side effects.
Comparative Effectiveness
When comparing treatment options for motion sickness:
- A Cochrane systematic review found that first-generation antihistamines (including promethazine) are probably more effective than placebo at preventing motion sickness symptoms under natural conditions (moderate-certainty evidence) 3
- However, antihistamines may be more likely to cause sedation compared to placebo (66% vs 44%) 3
- In experimental studies, autogenic-feedback training exercise (AFTE) was found to be significantly more effective than promethazine (both 25mg and 50mg doses) for controlling motion sickness symptoms 4
Practical Recommendations
For adults requiring motion sickness prevention:
- Start with lowest effective dose (12.5mg may be sufficient for some individuals)
- Time administration properly (30-60 minutes before travel)
- Monitor for sedation which may impair driving or operation of machinery
- Consider alternatives for patients with contraindications or who cannot tolerate side effects
Monitoring
Patients should be monitored for:
- Excessive sedation
- Respiratory depression
- Paradoxical reactions (hyperexcitability and abnormal movements) 1
- Cardiovascular effects (though a study showed minimal effects on autonomic cardiovascular mechanisms) 5
For most healthy adults, promethazine remains a reasonable option for motion sickness when used as directed, but the significant side effect profile should be considered when selecting treatment.